abstract |
Antibodies that selectively bind to glycosylated PD-1 relative to non-glycosylated PD-1 are provided. In some aspects, PD-1 polypeptides that include glycosylated amino acid positions are also provided. Also provided are methods of making and using such antibodies and polypeptides (eg, for the treatment of cancer). |